Elsevier

Placenta

Volume 100, October 2020, Pages 89-95
Placenta

Determinants of placental leptin receptor gene expression and association with measures at birth

https://doi.org/10.1016/j.placenta.2020.08.010Get rights and content

Highlights

  • Maternal factors are not a key determinant of placental LEPR expression.

  • Genetic variation in LEPR is a key determinant of placental LEPR expression.

  • Placental LEPR expression is associated with inflammation in umbilical cord blood.

Abstract

Introduction

The leptin signalling pathway is important in metabolic health during pregnancy. However, few studies have investigated the determinants and extent of leptin receptor gene (LEPR) expression in the placenta, nor the relationship with infant health in early life. Here, we investigate the genetic and maternal in utero determinants of placental LEPR expression, and whether this expression is linked to anthropometric and inflammatory measures at birth in healthy newborns in the Barwon Infant Study.

Methods

Placental LEPR expression was measured using RT-qPCR (n = 854 placentae). Associations between genetic variation in LEPR, maternal in utero factors, measures at birth and placental LEPR expression were assessed using multivariable linear regression modelling.

Results

We found that the genotype at two intronic SNPs, rs9436301 and rs9436746, was independently associated with placental LEPR expression. Maternal pre-pregnancy body mass index, gestational diabetes mellitus, weight gain and smoking in pregnancy were not associated with LEPR expression. Placental LEPR expression was negatively associated with high sensitivity C-Reactive Protein in umbilical cord blood, which persisted after adjustment for potential confounders.

Discussion

Overall, our findings suggest that genetic variation in LEPR plays a key role in regulating placental LEPR expression, which is in turn is associated with inflammatory markers in cord blood at birth. Further studies encompassing other aspects of leptin signalling are warranted to understand if these relationships are causal and have health implications.

Introduction

Obesity is a major global health issue, and a key modifiable risk factor for cardiovascular and metabolic (cardiometabolic) diseases [1,2]. It is now clear that pathways to obesity and associated disease begin very early in life [3,4] and understanding their determinants is imperative to inform intervention strategies; which are more likely to be effective earlier in the life course [5].

The Developmental Origins of Health and Disease paradigm proposes that pregnancy is a critical period of developmental plasticity, and that adverse exposures during this period can induce long term changes in health [6,7]. The placenta plays a vital role in development as it regulates maternal-fetal exchanges [8]. Indeed, epidemiological studies have linked dysregulation of placental function to adverse later life health [9,10].

Leptin is a pro-inflammatory adipokine that functions as a hormone regulating energy homeostasis and fat storage [11]. It is also important in pregnancy across different species, where leptin levels increase in the maternal circulations [12]. This is primarily due to increased leptin production by the placenta, although the amount of placental leptin expressed is species-specific [[12], [13], [14]]. Leptin binds to the leptin receptor [12]. Previous studies have identified single nucleotide polymorphisms (SNPs) in the leptin receptor gene, LEPR, associated with obesity [[15], [16], [17], [18]] and inflammation in adults [[19], [20], [21], [22]]. Several recent studies have also identified expression quantitative trait loci (eQTLs) in the placenta [23,24], including one in LEPR [23]. However, previous studies have used a relatively small number of placental samples and as such this eQTL is yet to be validated. Additionally, few studies have examined the link between placental LEPR expression and early life phenotypes [25,26].

We therefore investigated the associations between genotype at SNPs in LEPR, maternal in utero factors and placental LEPR expression in healthy infants from the Barwon Infant Study (BIS). We then examined whether placental LEPR expression was associated with anthropometric and inflammatory measures at birth.

Section snippets

Study population and ethics

We analyzed data and samples from participants in the Barwon Infant Study (BIS), a population-derived, longitudinal pregnancy cohort study of 1074 mother and infant pairs established in Victoria, Australia. A detailed description of the cohort has been published previously [27]. Briefly, pregnant women were recruited during antenatal appointments at approximately 15 weeks of pregnancy between 2010 and 2013. Women were invited to participate if they resided within the Barwon region, were

Study population characteristics and placental LEPR expression

Of the 1074 BIS participants, 1022 had placenta RNA available. Following data cleaning, expression data was obtained for 854 infants; which were included in subsequent analyses. Characteristics of this study population are summarised in Table 1. Log10 placental LEPR expression in the study population ranged from −0.70 to 0.97 fold change compared to the median expression in the cohort. There was modest evidence that this expression was sex-specific, with lower levels in females (−0.035 [95% CI:

Main findings

Genotype at two intronic LEPR SNPs was associated with LEPR expression levels. However, there was no convincing evidence for an association of the investigated maternal pregnancy factors and expression. Placental LEPR expression was negatively associated with hsCRP in umbilical cord blood but was not associated with birth weight z-score or infant adiposity.

Genetic variation is associated with placental LEPR expression

To date, no previous studies have specifically explored the association between fetal genotype in LEPR and placental LEPR expression.

Conclusion

Overall, our findings indicate that genetic variation in LEPR plays a key role in regulating LEPR expression in the placenta, with potential consequences on leptin signalling and function in early development. These findings should be confirmed in further studies. Future studies should also extend on these findings to elucidate the causal nature of these relationships and potential underlying mechanisms, including examining both expression and epigenetic regulation of LEPR and LEP as well as

Data Availability

The datasets generated during and/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.

Contribution to authorship

A.V, R.S and T.M designed the study. A.V performed all experiments and statistical analyses, and wrote the manuscript. T.M extracted RNA from samples, provided assistance with the statistical analyses, performed GWAS analyses, and contributed to the interpretation of the results. B.N contributed to the planning of the experiments and interpretation of the results. D.B, F.C and R.S contributed to the interpretation of the results and manuscript writing. All authors discussed the results and

Declaration of competing interest

The authors have no conflict of interest to disclose.

Acknowledgements

We thank the Barwon Infant Study participants and their families for taking part in the study, as well as the staff who helped recruit and gather data. We also thank QIMR Berghofer Medical Research Institute and the Erasmus MC University Medical Centre for their role in coordinating and performing the genotyping of BIS samples. The establishment work and infrastructure for the BIS was provided by the Murdoch Children's Research Institute, Deakin University and Barwon Health. Subsequent funding

References (66)

  • M. Simmonds

    Predicting adult obesity from childhood obesity: A systematic review and meta-analysis

    Obes. Rev.

    (2016)
  • M.W. Gillman et al.

    How early should obesity prevention start?

    N. Engl. J. Med.

    (2013)
  • M.A. Hanson et al.

    Early developmental conditioning of later health and disease: physiology or pathophysiology?

    Physiol. Rev.

    (2014)
  • I.C. McMillen et al.

    Developmental origins of the metabolic syndrome: prediction, plasticity, and programming

    Physiol. Rev.

    (2005)
  • T. Jansson et al.

    Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches

    Clin. Sci.

    (2007)
  • D.J.P. Barker et al.

    The obstetric origins of health for a lifetime

    Clin. Obstet. Gynecol.

    (2013)
  • A. La Cava et al.

    The weight of leptin in immunity

    Nat. Rev. Immunol.

    (2004)
  • H. Masuzaki

    Nonadipose tissue production of leptin: leptin as a novel placenta- derived hormone in humans

    Nat. Med.

    (1997)
  • J. Lepercq

    Prenatal leptin production: evidence that fetal adipose tissue produces leptin

    J. Clin. Endocrinol. Metabol.

    (2001)
  • E. Wheeler

    Genome-wide SNP and CNV analysis identifies common and low-frequency variants associated with severe early-onset obesity

    Nat. Genet.

    (2013)
  • A.C. Alves

    GWAS on longitudinal growth traits reveals different genetic factors influencing infant, child, and adult BMI

    Science Advances

    (2019)
  • L.J. Tan

    Replication of 6 obesity genes in a meta-analysis of genome-wide association studies from diverse ancestries

    PloS One

    (2014)
  • N.D. Quinton

    A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women

    Hum. Genet.

    (2001)
  • A. Mahajan

    Common variants in CRP and LEPR influence high sensitivity C-reactive protein levels in North Indians

    PloS One

    (2011)
  • P. Navarro

    Relationship between polymorphisms in the CRP, LEP and LEPR genes and high sensitivity C-reactive protein levels in Spanish children

    Clin. Chem. Lab. Med.

    (2017)
  • A. Dehghan

    Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels

    Circulation

    (2011)
  • S. Peng

    Expression quantitative trait loci (eQTLs) in human placentas suggest developmental origins of complex diseases

    Hum. Mol. Genet.

    (2017)
  • T. Kikas

    The effect of genetic variation on the placental transcriptome in humans

    Front. Genet.

    (2019)
  • R.G. Lea

    Placental leptin in normal, diabetic and fetal growth-retarded pregnancies

    Mol. Hum. Reprod.

    (2000)
  • R. Iciek

    Placental leptin and its receptor genes expression in pregnancies complicated by type 1 diabetes

    J. Physiol. Pharmacol.

    (2013)
  • P. Vuillermin

    Cohort profile: the Barwon infant study

    Int. J. Epidemiol.

    (2015)
  • A. Nankervis

    Testing for gestational diabetes mellitus in Australia

    Diabetes Care

    (2013)
  • D. Trevisanuto

    High-sensitivity C-reactive protein in umbilical cord of small-for-gestational-age neonates

    Neonatology

    (2007)
  • Cited by (0)

    View full text